Conventional MRI

  • G. T. Ingle
  • A. J. Thompson
  • D. H. Miller
Part of the Topics in Neuroscience book series (TOPNEURO)


Conventional magnetic resonance (MR) images are obtained from the 1H nuclei in water and fat. The resolution of such images is usually 1 mm × 1 mm in plane with a slice thickness of either 3 or 5 mm. Different tissues can be distinguished by the difference in the density and macromolecular environment of their mobile protons. The intensity of tissue signals is influenced by three main parameters: proton density (PD), T1 relaxation time and T2 relaxation time. T1 and T2 relaxation times define the rate at which the nuclear MR signals decay after the radiofrequency excitation pulse ceases (T1: longitudinal relaxation i.e. parallel to the magnetic field; T2: transverse relaxation, i.e. perpendicular to the magnetic field). PD and T2-weighted spin echo sequences (or their more rapidly acquired modification, the fast spin echo) are the most widely used for diagnostic studies in multiple sclerosis (MS). They have high specificity for tissue abnormality and the relation between MRI and tissue abnormalities in MS has been studied using post-mortem material [1–3].


Expand Disability Status Scale Progressive Multiple Sclerosis Expand Disability Status Scale Score Lesion Load Primary Progressive Multiple Sclerosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stewart WA, Hall LD, Berry K, Paty DW (1984) Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet 2:412PubMedCrossRefGoogle Scholar
  2. 2.
    Newcombe J, Hawkins CP, Henderson CL et al (1991) Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 114:1013–1023PubMedCrossRefGoogle Scholar
  3. 3.
    van Waesberghe JH, Kamphorst W, De Groot CJ et al (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747–754PubMedCrossRefGoogle Scholar
  4. 4.
    Hawkins CP, Munro PM, MacKenzie F et al (1990) Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 113:365–378PubMedCrossRefGoogle Scholar
  5. 5.
    Katz D, Taubenberger JK, Cannella B et al (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34:661–669PubMedCrossRefGoogle Scholar
  6. 6.
    Nesbit GM, Forbes GS, Scheithauer BW et al (1991) Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180:467–474PubMedGoogle Scholar
  7. 7.
    Bruck W, Bitsch A, Kolenda H et al (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42:783–793PubMedCrossRefGoogle Scholar
  8. 8.
    Thompson AJ, Kermode AG, MacManus DG et al (1990) Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. Br Med J 300:631–634CrossRefGoogle Scholar
  9. 9.
    Filippi M, Campi A, Martinelli V et al (1995) A brain MRI study of different types of chronic-progressive multiple sclerosis. Acta Neurol Scand 91:231–233PubMedCrossRefGoogle Scholar
  10. 10.
    Gayou A, Brochet B, Dousset V (1997) Transitional progressive multiple sclerosis: a clinical and imaging study. J Neurol Neurosurg Psychiatry 63:396–398PubMedCrossRefGoogle Scholar
  11. 11.
    Lycklama à Nijeholt GJ, van Walderveen MA, Castelijns JA et al (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687–697CrossRefGoogle Scholar
  12. 12.
    Stevenson VL, Miller DH, Rovaris M et al (1999) Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 52:839–845PubMedGoogle Scholar
  13. 13.
    Filippi M, Iannucci G, Tortorella C et al (1999) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 52:588–594PubMedGoogle Scholar
  14. 14.
    Foong J, Rozewicz L, Chong WK et al (2000) A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J Neurol 247:97–101PubMedCrossRefGoogle Scholar
  15. 15.
    van Walderveen MA, Lycklama ANG, Ader HJ et al (2001) Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58:76–81CrossRefGoogle Scholar
  16. 16.
    Camp SJ, Stevenson VL, Thompson AJ et al (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 122:1341–1348PubMedCrossRefGoogle Scholar
  17. 17.
    Stevenson VL, Miller DH, Leary SM et al (2000) One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 68:713–718PubMedCrossRefGoogle Scholar
  18. 18.
    Thompson AJ, Kermode AG, Wicks D et al (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29:53–62PubMedCrossRefGoogle Scholar
  19. 19.
    Kidd D, Thorpe JW, Kendall BE et al (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 60:15–19PubMedCrossRefGoogle Scholar
  20. 20.
    Filippi M, Campi A, Martinelli V et al (1995) Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 59:540–544PubMedCrossRefGoogle Scholar
  21. 21.
    Silver NC, Good CD, Barker GJ et al (1997) Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 120:1149–1161PubMedCrossRefGoogle Scholar
  22. 22.
    Molyneux PD, Kappos L, Polman C et al (2000) The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. Brain 123:2256–2263PubMedCrossRefGoogle Scholar
  23. 23.
    Kidd D, Thorpe JW, Thompson AJ et al (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43:2632–2637PubMedGoogle Scholar
  24. 24.
    Thorpe JW, Kidd D, Moseley IF et al (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119:709–714PubMedCrossRefGoogle Scholar
  25. 25.
    Kremenchutzky M, Lee D, Rice GP, Ebers GC (2000) Diagnostic brain MRI findings in primary progressive multiple sclerosis. Mult Scler 6:81–85PubMedGoogle Scholar
  26. 26.
    Thompson AJ, Montalban X, Barkhof F et al (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835PubMedCrossRefGoogle Scholar
  27. 27.
    Filippi M, Bozzali M, Horsfield MA et al (2000) A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 54:207–213PubMedGoogle Scholar
  28. 28.
    Losseff NA, Webb SL, O’Riordan JI, Page R, Wang L et al (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119:701–708PubMedCrossRefGoogle Scholar
  29. 29.
    Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML et al (1996) Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 119:2009–2019PubMedCrossRefGoogle Scholar
  30. 30.
    Revesz T, Kidd D, Thompson AJ et al (1994) A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117:759–765PubMedCrossRefGoogle Scholar
  31. 31.
    Leary SM, Stevenson VL, Miller DH, Thompson AJ (1999) Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis. J Neurol 246:562–568PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2002

Authors and Affiliations

  • G. T. Ingle
  • A. J. Thompson
  • D. H. Miller

There are no affiliations available

Personalised recommendations